Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes.
about
Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic InterventionChemokines as Cancer Vaccine Adjuvants.CCL21 Cancer Immunotherapy.Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.Chemokines: agents for the immunotherapy of cancer?The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses.Multiple functions of CXCL12 in a syngeneic model of breast cancerChemokines and antitumor immunity: walking the tightrope.Local expression of secondary lymphoid tissue chemokine delivered by adeno-associated virus within the tumor bed stimulates strong anti-liver tumor immunity.Immune cell recruitment and cell-based system for cancer therapy.The anti-tumor effect and increased tregs infiltration mediated by rAAV-SLC vector.Regulated expression of CCL21 in the prostate tumor microenvironment inhibits tumor growth and metastasis in an orthotopic model of prostate cancer.Lymphatics: at the interface of immunity, tolerance, and tumor metastasis.Chemokine-based immunotherapy: delivery systems and combination therapies.Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunity.Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation.Anti‐tumor immunity induced by tumor cells express a membrane‐bound form of IL‐2 and SDF‐1
P2860
Q28073895-E7B3F558-059C-406F-B4C4-D9F9E9F326D7Q33792344-0FC6A8E6-D8A3-4B9D-BA9D-AE1F3A2A5BF3Q33820300-BCA1E689-AD72-46DB-B59A-685691833A4EQ34017734-C5A9937B-DAA2-41FD-83FF-943826C8D8C5Q34576416-9D93DB4D-1D5C-4F83-99F5-19880F566F15Q34929196-468166CD-60E1-4D04-876A-249C25AC5307Q34992480-28882D21-21A7-444F-8180-D2EF10B32C74Q35126970-E5781A8F-4DB7-440A-85BC-DB3656CC4AE5Q35947942-09C9B3FD-198A-450A-B692-BEF9BC64ED8CQ36517706-22CA1926-DF41-49B6-AAAA-5CEEFF55DB8BQ37298417-0957F0BE-B1D8-412F-BDEF-20A376178EA9Q37456503-7EFE13BC-38A4-4D2E-B471-6E0192B8DF95Q37875904-FAD24F29-B44C-4364-BCAB-FF6A63E97F56Q38040509-9F90711E-C270-4B9B-8FDF-E673F7C6F38AQ38172131-66C90B7F-F9D7-47DF-BD38-573C6698AF80Q44083586-94474296-9662-494C-A2D4-8B459DB2F407Q58286987-9402063D-C2C0-4608-BCD0-C63BEDD0AC9C
P2860
Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Enhancement of anti-tumor immu ...... factor-1alpha chemokine genes.
@ast
Enhancement of anti-tumor immu ...... factor-1alpha chemokine genes.
@en
type
label
Enhancement of anti-tumor immu ...... factor-1alpha chemokine genes.
@ast
Enhancement of anti-tumor immu ...... factor-1alpha chemokine genes.
@en
prefLabel
Enhancement of anti-tumor immu ...... factor-1alpha chemokine genes.
@ast
Enhancement of anti-tumor immu ...... factor-1alpha chemokine genes.
@en
P2093
P2860
P1476
Enhancement of anti-tumor immu ...... factor-1alpha chemokine genes.
@en
P2093
P2860
P304
P356
10.1002/1097-0215(200002)9999:9999<::AID-IJC1107>3.0.CO;2-J
P577
2001-03-01T00:00:00Z